Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-24-028510
Filing Date
2024-09-05
Accepted
2024-09-05 12:41:40
Documents
1
Period of Report
2024-09-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 6278
  Complete submission text file 0001437749-24-028510.txt   7991
Mailing Address 320 SOQUEL WAY SUNNYVALE CA 94085
Business Address 320 SOQUEL WAY SUNNYVALE CA 94085 650-226-0123
BioCardia, Inc. (Issuer) CIK: 0000925741 (see all company filings)

EIN.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O BIOCARDIA, INC. 125 SHOREWAY ROAD, SUITE B SAN CARLOS CA 94070
Business Address
Blank Andrew Scott (Reporting) CIK: 0001789894 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38999 | Film No.: 241280716